REBEKAH KIM: Open Payments
NPI 1447943006 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 39 payments from 15 companies in 2025. Trend: 2023 $485 · 2024 $2,196 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $228 |
| Janssen Biotech, Inc. | 2 | $205 |
| Phathom Pharmaceuticals, Inc. | 5 | $156 |
| Ardelyx, Inc. | 4 | $143 |
| Gilead Sciences, Inc. | 1 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| QOL Medical, LLC | 2 | $63 |
| PFIZER INC. | 2 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
Products named: TREMFYA, VOQUEZNA, IBSRELA, Vemlidy, SKYRIZI, RINVOQ, XIFAXAN, Sucraid.
Industry payments across GA — which companies pay providers there.
